Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Arthritis Rheum. 2013 Feb;65(2):314-24. doi: 10.1002/art.37754.
Arthritis Rheum. 2013.
PMID: 23124935
Free PMC article.
Clinical Trial.